Global Gene Panel Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Gene Panel Market is presumed to reach the market size of nearly USD 14.32 BN by 2030 from USD 3.29 BN in 2022 with a CAGR of 20.2% under the study period 2023 - 2030.

Gene panel is a diagnostic test used to narrow down a diagnosis when the patient shows symptoms that can be caused by a variety of conditions or when variants in multiple genes can cause the suspected condition. Gene panel tests can examine large numbers of genes which helps provide cancer information and provides a secure diagnosis to prevent cancer spread. Gene panel are used in diagnostics and treatments such as cancer risk assessment, syndrome-specific diagnostics, disease penetration, and many other applications.

MARKET DYNAMICS:

The significant factor attributing to the market's growth is the rising incidence and prevalence of chronic diseases. Moreover, increasing technological advancement in diagnostics services and modernization in healthcare techniques are driving the market's growth. Also, the growing ongoing research and development drive the gene panel market. Furthermore, the increasing number of cancer cases in males and females and the benefits of the gene panel market to fight cancer drive market growth. However, high prices and serious doubts among individuals about the authenticity of genetic reports are the major restraints of the gene panel market growth. In addition, growing awareness about the potential benefits of genetic testing, increasing demand for advanced medical testing, and rising demand for targeted approaches and personalized medicine are the primary drivers of the growth of the global gene panel market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gene panel. The growth and trends of gene panel industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the gene panel market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

Test Kits
Testing Services

By Technique

Amplicon-Based Approach
Hybridization-Based Approach

By Design

Predesigned Gene Panel
Customized Gene Panel

By Application

Cancer Risk Assessment (Syndrome-Specific, High-Penetrance, High And Moderate-Penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases)
Pharmacogenetics
Other Applications

By End User

Research And Academic Institutes
Hospital And Diagnostic Laboratories
Pharmaceutical And Biotechnology Companies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Gene Panel market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gene panel market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219275

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . GENE PANEL - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Technique
- 3.7.3 Market Attractiveness Analysis By Design
- 3.7.4 Market Attractiveness Analysis By Application
- 3.7.5 Market Attractiveness Analysis By End User
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL GENE PANEL MARKET ANALYSIS BY PRODUCT & SERVICE

6.1 Overview by Product & Service
6.2 Historical and Forecast Data
6.3 Analysis by Product & Service
6.4 Test Kits Historic and Forecast Sales by Regions
6.5 Testing Services Historic and Forecast Sales by Regions

7 . GLOBAL GENE PANEL MARKET ANALYSIS BY TECHNIQUE

7.1 Overview by Technique
7.2 Historical and Forecast Data
7.3 Analysis by Technique
7.4 Amplicon-based Approach Historic and Forecast Sales by Regions
7.5 Hybridization-based Approach Historic and Forecast Sales by Regions

8 . GLOBAL GENE PANEL MARKET ANALYSIS BY DESIGN

8.1 Overview by Design
8.2 Historical and Forecast Data
8.3 Analysis by Design
8.4 Predesigned Gene Panel Historic and Forecast Sales by Regions
8.5 Customized Gene Panel Historic and Forecast Sales by Regions

9 . GLOBAL GENE PANEL MARKET ANALYSIS BY APPLICATION

9.1 Overview by Application
9.2 Historical and Forecast Data
9.3 Analysis by Application
9.4 Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Historic and Forecast Sales by Regions
9.5 Pharmacogenetics Historic and Forecast Sales by Regions
9.6 Other Applications Historic and Forecast Sales by Regions

10 . GLOBAL GENE PANEL MARKET ANALYSIS BY END USER

10.1 Overview by End User
10.2 Historical and Forecast Data
10.3 Analysis by End User
10.4 Research And Academic Institutes Historic and Forecast Sales by Regions
10.5 Hospital And Diagnostic Laboratories Historic and Forecast Sales by Regions
10.6 Pharmaceutical And Biotechnology Companies Historic and Forecast Sales by Regions

11 . GLOBAL GENE PANEL MARKET ANALYSIS BY GEOGRAPHY

11.1. Top Company Share Analysis
11.2. Introduction
11.3. North America Sales Analysis
- 11.3.1. Overview, Historic and Forecast Sales Analysis
- 11.3.2. North America By Segment Sales Analysis
- 11.3.3. North America By Country Sales Analysis
- 11.3.4. United State Sales Analysis
- 11.3.5. Canada Sales Analysis
- 11.3.6. Mexico Sales Analysis
11.4. Europe Sales Analysis
- 11.4.1. Overview, Historic and Forecast Sales Analysis
- 11.4.2. Europe by Segment Sales Analysis
- 11.4.3. Europe by Country Sales Analysis
- 11.4.4. United Kingdom Sales Analysis
- 11.4.5. France Sales Analysis
- 11.4.6. Germany Sales Analysis
- 11.4.7. Italy Sales Analysis
- 11.4.8. Russia Sales Analysis
- 11.4.9. Rest Of Europe Sales Analysis
11.5. Asia Pacific Sales Analysis
- 11.5.1. Overview, Historic and Forecast Sales Analysis
- 11.5.2. Asia Pacific by Segment Sales Analysis
- 11.5.3. Asia Pacific by Country Sales Analysis
- 11.5.4. China Sales Analysis
- 11.5.5. India Sales Analysis
- 11.5.6. Japan Sales Analysis
- 11.5.7. South Korea Sales Analysis
- 11.5.8. Australia Sales Analysis
- 11.5.9. Rest Of Asia Pacific Sales Analysis
11.6. Latin America Sales Analysis
- 11.6.1. Overview, Historic and Forecast Sales Analysis
- 11.6.2. Latin America by Segment Sales Analysis
- 11.6.3. Latin America by Country Sales Analysis
- 11.6.4. Brazil Sales Analysis
- 11.6.5. Argentina Sales Analysis
- 11.6.6. Peru Sales Analysis
- 11.6.7. Chile Sales Analysis
- 11.6.8. Rest of Latin America Sales Analysis
11.7. Middle East & Africa Sales Analysis
- 11.7.1. Overview, Historic and Forecast Sales Analysis
- 11.7.2. Middle East & Africa by Segment Sales Analysis
- 11.7.3. Middle East & Africa by Country Sales Analysis
- 11.7.4. Saudi Arabia Sales Analysis
- 11.7.5. UAE Sales Analysis
- 11.7.6. Israel Sales Analysis
- 11.7.7. South Africa Sales Analysis
- 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE GENE PANEL COMPANIES

12.1. Gene Panel Market Competition
12.2. Partnership/Collaboration/Agreement
12.3. Merger And Acquisitions
12.4. New Product Launch
12.5. Other Developments

13 . COMPANY PROFILES OF GENE PANEL INDUSTRY

13.1. Company Share Analysis
13.2. Market Concentration Rate
13.3. Illumina Inc. (US)
- 13.3.1. Company Overview
- 13.3.2. Company Revenue
- 13.3.3. Products
- 13.3.4. Recent Developments
13.4. BGI (China)
- 13.4.1. Company Overview
- 13.4.2. Company Revenue
- 13.4.3. Products
- 13.4.4. Recent Developments
13.5. Agilent Technologies (US)
- 13.5.1. Company Overview
- 13.5.2. Company Revenue
- 13.5.3. Products
- 13.5.4. Recent Developments
13.6. Eurofins Scientific (US)
- 13.6.1. Company Overview
- 13.6.2. Company Revenue
- 13.6.3. Products
- 13.6.4. Recent Developments
13.7. QIAGEN (Germany)
- 13.7.1. Company Overview
- 13.7.2. Company Revenue
- 13.7.3. Products
- 13.7.4. Recent Developments
13.8. GENEWIZ Inc. (US)
- 13.8.1. Company Overview
- 13.8.2. Company Revenue
- 13.8.3. Products
- 13.8.4. Recent Developments
13.9. Novogene Corporation (China)
- 13.9.1. Company Overview
- 13.9.2. Company Revenue
- 13.9.3. Products
- 13.9.4. Recent Developments
13.10. Personalis (US)
- 13.10.1. Company Overview
- 13.10.2. Company Revenue
- 13.10.3. Products
- 13.10.4. Recent Developments
13.11. Thermo Fisher Scientific (US)
- 13.11.1. Company Overview
- 13.11.2. Company Revenue
- 13.11.3. Products
- 13.11.4. Recent Developments
13.12. F. Hoffmann-La Roche AG (SwitzerlAnd)
- 13.12.1. Company Overview
- 13.12.2. Company Revenue
- 13.12.3. Products
- 13.12.4. Recent Developments
13.13. Integrated DNA Technologies (IDT) (US)
- 13.13.1. Company Overview
- 13.13.2. Company Revenue
- 13.13.3. Products
- 13.13.4. Recent Developments
13.14. GATC Biotech AG (GATC Biotech) (Germany)
- 13.14.1. Company Overview
- 13.14.2. Company Revenue
- 13.14.3. Products
- 13.14.4. Recent Developments
13.15. ArcherDx (US)
- 13.15.1. Company Overview
- 13.15.2. Company Revenue
- 13.15.3. Products
- 13.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies